×
About 9,670 results

ALLMedicine™ Aphasia Center

Research & Reviews  3,306 results

Buccofacial apraxia in primary progressive aphasia.
https://doi.org/10.1016/j.cortex.2022.10.010
Cortex; a Journal Devoted to the Study of the Nervous Sys... Morihara K, Ota S et. al.

Dec 4th, 2022 - Buccofacial apraxia (BFA) is associated with nonfluent/agrammatic variant primary progressive aphasia (nfvPPA) as well as with the severity of apraxia of speech (AOS), a core symptom of nfvPPA. However, an association with agrammatism has not been...

Inter-hemispheric synchronicity and symmetry: The functional connectivity consequences ...
https://doi.org/10.1016/j.nicl.2022.103263
NeuroImage. Clinical; Tao Y, Tsapkini K et. al.

Dec 2nd, 2022 - Stroke and neurodegenerative diseases differ along several dimensions, including their temporal trajectories -abrupt onset versus slow disease progression. Despite these differences, they can give rise to very similar cognitive impairments, such a...

Temporal Overlap Between Gestures and Speech in Poststroke Aphasia: Is There a Compensa...
https://doi.org/10.1044/2022_JSLHR-22-00130
Journal of Speech, Language, and Hearing Research : JSLHR; Zhang H, Hinzen W

Dec 2nd, 2022 - If language production is impaired, will gestures compensate? Evidence in favor of this prediction has often been argued to come from aphasia, but it remains contested. Here, we tested whether thought content not present in speech due to language ...

Forecasting immune effector cell-associated neurotoxicity syndrome after chimeric antig...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716920
Journal for Immunotherapy of Cancer; Amidi Y, Eckhardt CA et. al.

Dec 1st, 2022 - Immune effector cell-associated neurotoxicity syndrome (ICANS) is a clinical and neuropsychiatric syndrome that can occur days to weeks following administration chimeric antigen receptor (CAR) T-cell therapy. Manifestations of ICANS range from enc...

A phase II randomised controlled trial evaluating the feasibility and preliminary effic...
https://doi.org/10.1080/10749357.2022.2145736
Topics in Stroke Rehabilitation; Sekhon JK, Oates J et. al.

Nov 29th, 2022 - Speech-language pathologists (SLPs) utilize counseling to support the psychological wellbeing of people with post-stroke aphasia, however, SLPs receive variable, usually limited, counseling education. Counseling education may be effective in impro...

see more →

Guidelines  1 results

Return to Work for People With Aphasia.
https://doi.org/10.1016/j.apmr.2021.12.020
Archives of Physical Medicine and Rehabilitation; Gilmore N, Fraas M et. al.

Apr 9th, 2022 - Return to Work for People With Aphasia.|2022|Gilmore N,Fraas M,Hinckley J,|

see more →

Drugs  26 results see all →

Clinicaltrials.gov  365 results

Determining Learning Ability in People With Aphasia
https://clinicaltrials.gov/ct2/show/NCT05119023

Oct 14th, 2022 - Aphasia is an impairment in the expression or comprehension of language that can limit people's ability to communicate needs, reduce comprehension in complex environments, and prevent a return to work or limit participation in everyday life activi...

Recovery of Consciousness Following Intracerebral Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT03990558

Oct 13th, 2022 - Unconsciousness is common after an acute brain injury such as a brain hemorrhage, and recovery is poorly understood. This lack of knowledge is a key impediment to the development of novel strategies to improve outcomes and is one of the main reaso...

Effects of Usage of Simvastatin in Mild to Moderate Traumatic Brain Injury (TBI) Patients. Could it Make a Difference?
https://clinicaltrials.gov/ct2/show/NCT05551871

Oct 10th, 2022 - TBI is defined as an alteration in brain function, or other evidence of brain pathology, caused by an external force. [A] Alteration in brain function is defined as 1 of the following clinical signs: Any period of loss of or a decreased level of c...

Prospective Cohort Study : Evaluation of Prognosis Criteria for Walking Independently Recovery After Stroke.
https://clinicaltrials.gov/ct2/show/NCT05572892

Oct 10th, 2022 - Primary objective : Evaluation of the performance of the TWIST algorithm in predicting to walking independently recovery after stroke. Secondary objectives: Analysis of other factors that may influence walking recovery. Define for which patient pr...

Effects of Transcranial Direct Current Stimulation (tDCS) on Brain Organization and Naming in Aphasic Patients.
https://clinicaltrials.gov/ct2/show/NCT05570578

Oct 10th, 2022 - Functional connectivity (FC) represents a means of analyzing functional interactions in the brain network by assessing the statistical dependence of neural activity between brain areas. The brain maintains a high level of interactions between brai...

see more →

News  149 results

CAR T-Cell Therapies Improve Treatment Landscape in Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/car-t-cell-therapies-improve-treatment-landscape-in-relapsed-refractory-multiple-myeloma

Nov 21st, 2022 - The increasing integration of CAR T-cell therapies into the treatment paradigm for adult patients with relapsed or refractory multiple myeloma addresses several unmet needs and improves outcomes for this historically limited patient population, ac...

Adagrasib Delivers Durable CNS-Specific Activity in KRAS G12C+ NSCLC
https://www.onclive.com/view/adagrasib-delivers-durable-cns-specific-activity-in-kras-g12c-nsclc

Sep 29th, 2022 - Adagrasib (MRTX849) led to an intracranial objective response rate (ORR) of 32% and a median intracranial duration of response (DOR) that was not reached in patients with KRAS G12C–mutant non–small cell lung cancer (NSCLC) and active, untreated ce...

Dr. Paul on the Management of CRS and ICANS After CAR T-cell Therapy in Cancer Care
https://www.onclive.com/view/dr-paul-on-the-management-of-crs-and-icans-after-car-t-cell-therapy-in-cancer-care

Sep 27th, 2022 - Barry Paul, MD, assistant professor, the Division of Plasma Cell Disorders, the Department of Hematologic Oncology and Blood Disorders, Atrium Health, discusses the management of cytokine release syndrome (CRS) and immune effector cell–associated ...

Distinguishing Primary Progressive Aphasia Subtypes: New Data
https://www.medscape.com/viewarticle/981354

Sep 23rd, 2022 - The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways High tCr and low glutamate+glutamine (Glx) metabolite levels in the left inferior frontal gyrus (IFG) correlate with gre...

NCCN Releases New Guidelines for Pediatric CNS Cancers
https://www.onclive.com/view/nccn-releases-new-guidelines-for-pediatric-cns-cancers

Jul 13th, 2022 - The National Comprehensive Cancer Network (NCCN) issued recommendations for providers treating children with brain cancers, the second-most-common pediatric malignancy and the leading cause of cancer-related death in children.1-3 Approximately 15...

see more →

Patient Education  21 results see all →